Vaccines Market 2021 - By Type (Anti-Infective Vaccines, Anti-Cancer Vaccines, Others), By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Other Technologies), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Other Route of Administration), By Valance (Monovalent, Multivalent), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales), And By Region, Opportunities And Strategies – Global Forecast To 2030

aboutimg
Purchase Options
Request Sample
Request For Discount

Starting Price : $5000.00 | Pages : 279 | Published : September 2021 | SKU CODE : | Format :

Request Sample
Description Table Of Contents Tables & Figures Market Insights Related Reports

Vaccines Market Definition

The vaccines market consists of sales of vaccines and related services by entities (organizations, sole traders and partnerships) that produce vaccines to prevent various diseases. Vaccines are biological preparations that stimulate the immune system and prepare it to fight future infections caused by pathogens. They trigger the production of antibodies against pathogens or any foreign matter that enters the body.  Vaccines can be administered orally, through injections or by aerosol.  Vaccine doses are administered to both children (pediatric vaccines) and adults based on the schedule set for each vaccine. For adults, the vaccines are recommended based on age, health condition, prior vaccinations and occupation. The vaccines market is segmented into anti-infective vaccines; anti-cancer vaccines; and other-vaccines. Only goods and services traded between entities or sold to end consumers are included.

Vaccines are preventative medicines which are administered to the general population or to those vulnerable in a population as a precautionary measure to combat a disease, they may include single or multiple doses. Vaccines work by mimicking the infectious bacteria or virus that cause a disease. They energize the body’s immune system to build up a defensive mechanism against the infectious virus or bacteria without causing the disease. Vaccines contain weakened versions of bacteria or virus, and some contain only part of the bacteria or virus. Specific vaccines also contain only the genetic material for a specific protein which directs the body to produce similar type of protein.

Vaccines Market Size

The global vaccines market reached a value of nearly $59,151.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 10.4% since 2015. The market is expected to grow from $59,151.5 million in 2020 to $86,661.4 million in 2025 at a rate of 7.9%. The vaccines market is then expected to grow at a CAGR of 6.7% from 2025 and reach $119,881.2 million in 2030.  

Growth in the historic period in the vaccines market resulted from continuous protection towards infectious diseases, immunization policies to eradicate endemic diseases, increase in healthcare access, rising awareness of immunization, and increased funding for vaccine development. The market was restrained by long vaccine development and manufacturing timelines, low market access to vaccines for poor-income countries, and vaccine hesitancy.

Going forward, increasing cases of invasive cervical cancer, coronavirus outbreak, strong late-stage pipeline and new drug approvals, and prevalence of infectious diseases among children will drive the growth in the vaccines market. Factors that could hinder the growth of the market in the future include vaccine refusal by parents, skilled workforce shortages, and stringent regulations related to vaccines approvals.

Vaccines Market Drivers

The key drivers of the vaccines market included:

Immunization Policies To Eradicate Endemic Diseases

Governments across the globe are heavily focused on minimizing the global disease burden, specifically for vaccine-preventable diseases. Government surveillance in all countries has become active in ensuring that every individual is vaccinated with those recommended by the World Health Organization (WHO) at minimum or no cost. Every year, vaccination saves nearly 4-5 million people globally, from infectious diseases such as diphtheria, pertussis, tetanus, hepatitis, measles and polio. For instance, in May 2017, the pneumococcal conjugate vaccine was rolled out by the Universal Immunization Program (UPI), a vaccination programme launched by the Government of India to 2.1 million children in Himachal Pradesh and parts of Bihar in India. This demand for immunization globally was one of the driving factors for the growth of the vaccine market.

Vaccines Market Restraints

The key restraints on the vaccines market include:

Long Vaccine Development And Manufacturing Timelines

Due to complexities in production and associated procedures, vaccine development is considered to be a costly, complex, and time taking procedure, often lasting for about 10–15 years. Following this, vaccines enter different clinical trial phases after the manufacturer produces adequate preclinical data on safety to validate the vaccines’ activity in humans. Even after approval, vaccine batches are tested for safety and stability as part of the process each year to ensure their adherence to the regulatory guidelines. Moreover, the longer the timeline, the higher the manufacturing cost which limits the entry of new manufacturers into the market and hinders the market’s growth.

Vaccines Market Trends

Major trends shaping the vaccines market include the following –

Synthetic Biology In Vaccine Development

Synthetic biology is gaining popularity among companies that are developing vaccines. Synthetic biology is a field of biology which involves engineering principles, whereby organisms are redesigned for useful purposes by engineering them to have new abilities. Synthetic biology tools significantly aid in drug discovery processes to help understand the molecular mechanisms of target diseases. Traditionally, vaccines are developed using the whole organism. Synthetic vaccines are based on complex carbohydrate-protein conjugates and can be easily stored at normal temperature without the need for refrigeration. Synthetic biology technologies such as DNA- and mRNA-based vaccine technologies allow researchers to read and write DNA quite readily and develop innovative vaccines easily. In 2020, the US National Institute of Health identified the importance of synthetic biology to speed up vaccine development. For example, in February 2020, the Bill & Melinda Gates Foundation funded $60 million to COVID-19 research and vaccine developments based on synthetic biology.

Development Of Combination Vaccines

There has been an increasing demand for combination vaccines among infants and children. Combination vaccines are a combination of multiple vaccines into one. The development of combination vaccines for protection against multiple diseases was initiated by combining separate vaccines against tetanus, diphtheria, and pertussis into a single dose. The combination vaccines simplify childhood immunization schedules and reduce the number of injections while protecting against several serious diseases. The parents have fewer visits to doctor, less hassle, cost effective and time effective. The babies have to take fewer shots implying less pain and discomfort. Many companies have started developing combination vaccines as the demand increased. For instance, in October 2020, Merck and Sanofi Pasteur a U.S.-based joint-partnership vaccine company developed, manufactured and marketed, VAXELIS, a combination vaccine for Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B.

Opportunities And Recommendations In Vaccine Market

Opportunities –The top opportunities in the vaccines market segmented by type will arise in anti-infective vaccines segment, which will gain $24,973.8 million of global annual sales by 2025. The top opportunities in the vaccines market segmented by technology will arise in conjugate vaccines segment, which will gain $12,647.6 million of global annual sales by 2025. The top opportunities in the vaccines market segmented by route of administration will arise in intramuscular (IM) segment, which will gain $12,388.6 million of global annual sales by 2025. The top opportunities in the vaccines market segmented by valance will arise in multivalent segment, which will gain $20,610.1 million of global annual sales by 2025. The top opportunities in the vaccines market segmented by distribution channel will arise in hospital pharmacies segment, which will gain $17,946.8 million of global annual sales by 2025.  The vaccines market size will gain the most in the USA at $11,573.4 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the vaccine manufacturing companies to consider IoT technology in vaccine manufacturing and focus customized air separation plants to improve quality and achieve optimum production, establishing operations in emerging markets to gain market share, scale up through mergers and acquisition, focus on offering competitive pricing , increase visibility through websites and focus on new application industries among other strategies.

Vaccines Market Segmentation

The vaccines market is segmented by type, by technology, by route of administration, by valance and by distribution channel.
By Type -
The vaccines market is segmented by type into
    • a. Anti-Infective Vaccines
    • b. Anti-Cancer Vaccines
    • c. Others
The anti-infective vaccines segment was the largest segment of the vaccines market segmented by type, accounting for 87.1% of the total in 2020. Going forward, the anti-infective vaccines segment is expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 8.2% during 2020-2025.
By Technology –
The vaccines market is segmented by technology into
    • a. Conjugate Vaccines
    • b. Inactivated And Subunit Vaccines
    • c. Live Attenuated Vaccines
    • d. Recombinant Vaccines
    • e. Toxoid Vaccines
    • f. Other Technologies
The conjugate vaccines segment was the largest segment of the vaccines market segmented by technology, accounting for 43.8% of the total in 2020. Going forward, the recombinant vaccines segment is expected to be the fastest growing segment in the vaccines market segmented by technology, at a CAGR of 7.5% during 2020-2025.
By Route of Administration –
The vaccines market is segmented by route of administration into
    • a. Intramuscular (IM)
    • b. Subcutaneous (SC)
    • c. Oral
    • d. Other Route of Administration
The Intramuscular (IM) segment was the largest segment of the vaccines market segmented by route of administration, accounting for 47.4% of the total in 2020. Going forward, the other route of administration segment is expected to be the fastest growing segment in the vaccines market segmented by route of administration, at a CAGR of 8.6% during 2020-2025.
By Valance –
The vaccines market is segmented by valance into
    • a. Monovalent
    • b. Multivalent
The vaccines market is also segmented by valance into monovalent, and multivalent. The multivalent segment was the largest segment of the vaccines market segmented by valance, accounting for 65.4% of the total in 2020. Going forward, the multivalent segment is expected to be the fastest growing segment in the vaccines market segmented by valance, at a CAGR of 8.9% during 2020-2025.
By Distribution Channel –
The vaccines market is segmented by distribution channel into
    • a. Hospital Pharmacies
    • b. Retail Pharmacies
    • c. Institutional Sales
The hospital pharmacies segment was the largest segment of the vaccines market segmented by distribution channel, accounting for 65.3% of the total in 2020. Going forward, the retail pharmacies segment is expected to be the fastest growing segment in the vaccines market segmented by distribution channel, at a CAGR of 8.3% during 2020-2025.
By Geography-
The vaccines market is segment by geography into
      o North America
      • • USA
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the vaccines market, accounting for 44.8% of the total in 2020. It was followed by the Asia-Pacific, Western Europe then the other regions. Going forward, the fastest-growing regions in the vaccines market will be South America and Asia-Pacific where growth will be at CAGRs of 11.5% and 8.6% respectively during 2020-2025. These will be followed by Eastern Europe and Africa, where the markets are expected to register CAGRs of 8.5% and 8.4% respectively during 2020-2025.

Vaccines Competitive Landscape

Major Competitors In The Vaccines Market Are:

  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Pfizer Inc.
  • CSL Limited

    • Other Competitors In The Vaccines Market Include:

  • Serum Institute of India Pvt. Ltd.
  • Emergent BioSolutions Inc.
  • BioNTech SE
  • Daiichi Sankyo Company, Limited
  • AstraZeneca
  • Denteric Pvt Ltd.
  • Hualan Biological Engineering Inc.
  • Chongqing Zhifei
  • Beijing Tiantan Biological Products Co., Ltd
  • BioKangtai
  • CanSino Biologics
  • Takeda Pharmaceutical Company
  • Mitsubishi Tanabe Pharma Corporation
  • Indian Immunologicals Limited
  • Serum Institute of India Pvt. Ltd
  • Zydus Cadila
  • Panacea Biotec Ltd
  • BIO-MED
  • Sinovac Biotech Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Sinopharm
  • Walvax biotechnology
  • Fosun Pharma
  • Valneva SE
  • BioFabri
  • ImevaX GmbH
  • Bayer
  • Boehringer Ingelheim
  • Novartis
  • MCM Vaccine Company
  • Seqirus
  • Roche
  • Johnson & Johnson
  • Connaught Laboratories, Inc.
  • Wyeth-Ayerst
  • Grifols
  • Fiocruz
  • Sinergium Biotech SA.
  • Ataulfo de Paiva Foundation
  • Bio-Manguinhos-Institute of Technology on Immunobiologicals
  • Butantan Institute, Ezequiel Dias Foundation (FUNED)
  • National Administration of Laboratories and Institutes of Health (ANLIS)
  • Arabio
  • MIGAL Galilee Research Institute
  • Hayat-Vax
  • Phaax
  • VPS Health Care
  • Biovac Institute

      • Table Of Contents

      1. Vaccines Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1. Segmentation By Geography

      6.2. Segmentation By Type

      6.3. Segmentation By Technology

      6.4. Segmentation By Route of Administration

      6.5. Segmentation By Valance

      6.6. Segmentation By Distribution Channel

      7. Vaccines Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Type

      7.2.1. Anti-Infective Vaccines

      7.2.2. Anti-Cancer Vaccines

      7.2.3. Others

      7.3. Market Segmentation By Technology

      7.3.1. Conjugate Vaccines

      7.3.2. Inactivated And Subunit Vaccines

      7.3.3. Live Attenuated Vaccines

      7.3.4. Recombinant Vaccines

      7.3.5. Toxoid Vaccines

      7.3.6. Other Technologies

      7.4. Market Segmentation By Route Of Administration

      7.4.1. Intramuscular (IM)

      7.4.2. Subcutaneous (SC)

      7.4.3. Oral

      7.4.4. Other Route of Administration

      7.5. Market Segmentation By Valance

      7.5.1. Monovalent

      7.5.2. Multivalent

      7.6. Market Segmentation By Distribution Channel

      7.6.1. Hospital Pharmacies

      7.6.2. Retail Pharmacies

      7.6.3. Institutional Sales

      8. Vaccines Market Trends And Strategies

      8.1. Synthetic Biology In Vaccine Development

      8.2. Development Of Combination Vaccines

      8.3. Robust Research And Development

      8.4. Increasing Demand For Conjugate Vaccines

      8.5. Artificial Intelligence In Vaccine Development

      8.6. mRNA Vaccines

      8.7. Cancer Vaccines

      9. Impact Of COVID-19 On The Vaccines Market

      9.1. Introduction

      9.2. Disruptions In Regular Vaccination Campaigns

      9.3. Government Measures And Support For The Development Of Vaccines

      9.4. COVID-19 Vaccines And Vaccination Strategies

      9.5. Delay In COVID-19 Vaccine Development Activities

      9.6. Future Outlook

      10. Global Vaccines Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2020 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Vaccines Market Segmentation

      11.1. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2. Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3. Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3.1. Intramuscular (IM) Route Of Administration

      11.3.2. Subcutaneous (SC) Route Of Administration

      11.3.3. Other Route Of Administration

      11.3.4. Oral Route Of Administration

      11.4. Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.4.1. Multivalent

      11.4.2. Monovalent

      11.5. Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.5.1. Hospital Pharmacies

      11.5.2. Retail Pharmacies

      11.5.3. Institutional Sale

      12. Vaccines Market, Regional And Country Analysis

      12.1. Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Vaccines Market

      13.1. Asia-Pacific Vaccines Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. COVID-19 Impact

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7. Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Investments

      13.1.10. Taxes Levied

      13.1.11. Corporate Tax Structure

      13.1.12. Major Companies

      13.2. Asia-Pacific Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3. Asia-Pacific Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5. Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.6. Asia-Pacific Vaccines Market: Country Analysis

      13.7. China Vaccines Market

      13.8. China Vaccines Market Overview

      13.8.1. Country Information

      13.8.2. Market Information

      13.8.3. COVID-19 Impact

      13.8.4. Background Information

      13.8.5. Government Initiatives

      13.8.6. Regulations

      13.8.7. Regulatory Bodies

      13.8.8. Major Associations

      13.8.9. Investments

      13.8.10. Taxes Levied

      13.8.11. Corporate Tax Structure

      13.8.12. Major Companies

      13.9. China Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.10. China Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.11. China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.12. China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.13. India Vaccines Market

      13.14. India Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.15. India Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.16. India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.17. India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.18. Japan Vaccines Market

      13.19. Japan Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.20. Japan Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.21. Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.22. Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23. Australia Vaccines Market

      13.24. Australia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25. Australia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.26. Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27. Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.28. Indonesia Vaccines Market

      13.29. Indonesia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.30. Indonesia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.31. Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.32. Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.33. South Korea Vaccines Market

      13.34. South Korea Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.35. South Korea Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.36. South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.37. South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Vaccines Market

      14.1. Western Europe Vaccines Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. COVID-19 Impact

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.6. Western Europe Vaccines Market: Country Analysis

      14.7. UK Vaccines Market

      14.8. UK Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.9. UK Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.10. UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.11. UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.12. Germany Vaccines Market

      14.13. Germany Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.14. Germany Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.15. Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.16. Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.17. France Vaccines Market

      14.18. France Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.19. France Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.20. France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.21. France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Vaccines Market

      15.1. Eastern Europe Vaccines Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. COVID-19 Impact

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7. Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Investments

      15.1.10. Taxes Levied

      15.1.11. Corporate Tax Structure

      15.1.12. Major Companies

      15.2. Eastern Europe Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3. Eastern Europe Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5. Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.6. Eastern Europe Vaccines Market: Country Analysis

      15.7. Russia Vaccines Market

      15.8. Russia Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.9. Russia Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.10. Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.11. Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Vaccines Market

      16.1. North America Vaccines Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. COVID-19 Impact

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Corporate Tax Structure

      16.1.10. Taxes Levied

      16.1.11. Investments

      16.1.12. Major Companies

      16.2. North America Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.6. North America Vaccines Market: Country Analysis

      16.7. USA Vaccines Market

      16.8. USA Vaccines Market Overview

      16.8.1. Country Information

      16.8.2. Market Information

      16.8.3. COVID-19 Impact

      16.8.4. Background Information

      16.8.5. Government Initiatives

      16.8.6. Regulations

      16.8.7. Regulatory Bodies

      16.8.8. Major Associations

      16.8.9. Corporate Tax Structure

      16.8.10. Taxes Levied

      16.8.11. Investments

      16.8.12. Major Companies

      16.9. USA Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.10. USA Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.11. USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.12. USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Vaccines Market

      17.1. South America Vaccines Market Overview

      17.1.1. Region Information

      17.1.2. Market Information

      17.1.3. Impact of COVID-19

      17.1.4. Background Information

      17.1.5. Government Initiatives

      17.1.6. Regulations

      17.1.7. Regulatory Bodies

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2. South America Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4. South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.6. South America Vaccines Market: Country Analysis

      17.7. Brazil Vaccines Market

      17.8. Brazil Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.9. Brazil Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.10. Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.11. Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Vaccines Market

      18.1. Middle East Vaccines Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Impact of COVID-19

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulatory Bodies

      18.1.7. Regulations

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18.5. Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Vaccines Market

      19.1. Africa Vaccines Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes Levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Africa Vaccines Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa Vaccines Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19.5. Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20. Global Vaccines Market Competitive Landscape

      20.1. Company Profiles

      20.2. GlaxoSmithKline plc

      20.2.1. Company Overview

      20.2.2. Products And Services

      20.2.3. Business Strategy

      20.2.4. Financial Overview

      20.3. Merck & Co., Inc.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Sanofi S.A.

      20.4.1. Company Overview

      20.4.2. Products And Services

      20.4.3. Business Strategy

      20.4.4. Financial Overview

      20.5. Pfizer Inc.

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. CSL Limited

      20.6.1. Company Overview

      20.6.2. Products And Services

      20.6.3. Business Strategy

      20.6.4. Financial Overview

      21. Vaccines Pipeline Analysis

      22. Key Mergers And Acquisitions In The Vaccines Market

      22.1. Sanofi S.A. Acquired Kymab Ltd

      22.2. BioNTech SE Acquired GMP Certified Manufacturing Site Of Novartis AG

      22.3. GlaxoSmithKline plc Acquired 10% Stake In CureVac For $163.67 million

      22.4. Novavax, Inc. Acquired Praha Vaccines For $167 million

      22.5. Bavarian Nordic A/S Acquired Global Rights For Two Vaccines from GSK For $940.07 Million

      22.6. Bharat Biotech International Limited Acquired Chiron Behring Vaccines From GlaxoSmithKline

      22.7. Emergent BioSolutions Inc. Acquired PaxVax Corporation For $270 Million

      22.8. Sanofi Pasteur Acquired Protein Sciences

      23. Vaccines Market Future Outlook and Potential Analysis

      23.1. Global Vaccines Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Vaccines Market In 2025 – Segments Offering Most New Opportunities

      23.3. Global Vaccines Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24. Appendix

      24.1. Market Data Sources

      24.2. Research Methodology

      24.3. Currencies

      24.4. Research Inquiries

      24.5. The Business Research Company

      24.6. Copyright And Disclaimer

    List Of Tables

      Table 1: Global Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 14: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 15: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 16: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 17: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
    • Table 18: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 19: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 20: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 21: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 22:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 23: Asia-Pacific Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 24: Asia-Pacific Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 25: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 26: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 27: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 28: Asia-Pacific Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 29: China Vaccine Market, COVID-19 Vaccines Approvals
    • Table 30: China GDP Per Capita, 2015-2020, $
    • Table 31: China, Population By Age Group, 2015-2023, Thousands
    • Table 32:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 33: China Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 34: China Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 35: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 36: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 37: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 38: China Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 39: India Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 40: India Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 41: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 42: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 43: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 44: India Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 45: Japan Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 46: Japan Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 47: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 48: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 49: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 50: Japan Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 51: Australia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 52: Australia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 53: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 54: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 55: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 56: Australia Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 57: Indonesia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 58: Indonesia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 59: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 60: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 61: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 62: Indonesia Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 63: South Korea Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 64: South Korea Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 65: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 66: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 67: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 68: South Korea Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 69: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
    • Table 70: Western Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 71: Western Europe GDP Per Capita, 2015-2020, $
    • Table 72: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 73:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 74:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 75: Western Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 76: Western Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 77: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 78: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 79: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 80: Western Europe Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 81: UK Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 82: UK Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 83: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 84: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 85: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 86: UK Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 87: Germany Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 88: Germany Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 89: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 90: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 91: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 92: Germany Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 93: France Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 94: France Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 95: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 96: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 97: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 98: France Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 99: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
    • Table 100: Eastern Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 101: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 102: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 103:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 104:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 105: Eastern Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 106: Eastern Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 107: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 108: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 109: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 110: Eastern Europe Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 111: Russia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 112: Russia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 113: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 114: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 115: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 116: Russia Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 117: North America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 118: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 119: North America GDP Per Capita, 2015-2020, $
    • Table 120: North America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 121:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 122:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
    • Table 123: North America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 124: North America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 125: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 126: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 127: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 128: North America Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 129: USA Vaccine Market, COVID-19 Vaccines Approvals
    • Table 130: USA GDP Per Capita, 2015-2020, $
    • Table 131: USA, Population By Age Group, 2015-2023, Thousands
    • Table 132:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 133: USA Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 134: USA Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 135: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 136: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 137: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 138: USA Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 139: South America Vaccine Market, COVID-19 Vaccines Approvals
    • Table 140: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 141: South America GDP Per Capita, 2015-2020, $
    • Table 142: South America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 143:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 144:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 145: South America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 146: South America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 147: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 148: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 149: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 150: South America Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 151: Brazil Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 152: Brazil Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 153: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 154: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 155: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 156: Brazil Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 157: Middle East Vaccine Market, COVID-19 Vaccines Approvals
    • Table 158: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 159: Middle East GDP Per Capita, 2015-2020, $
    • Table 160: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 161:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 162:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 163: Middle East Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 164: Middle East Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 165: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 166: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 167: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 168: Middle East Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 169: Africa Vaccine Market, COVID-19 Vaccines Approvals
    • Table 170: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
    • Table 171: Africa GDP Per Capita, 2015-2020, $
    • Table 172: Africa, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 173: Africa Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 174: Africa Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 175: Africa Vaccines Market, Historic, 2015 – 2020, $ Million
    • Table 176: Africa Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 177: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 178: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 179: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 180: Africa Vaccines Market, Segmentation By Product, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 181: Global Vaccines Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 182: GlaxoSmithKline plc – Financial Performance, 2016 – 2020, $ Billion
    • Table 183: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Table 184: Sanofi S.A. – Financial Performance, 2016 – 2020, $ Billion
    • Table 185: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Table 186: CSL Limited – Financial Performance, 2016 – 2020, $ Billion
    • Table 187: Global Vaccine Market, Product Pipeline Analysis
    • Table 188: Global Vaccines Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 189: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2020 – 2025
    • Table 190: Global Vaccines Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 191: Global Vaccines Market Size Gain ($ Million), Segmentation By Route of Administration, 2020 – 2025
    • Table 192: Global Vaccines Market Size Gain ($ Million), Segmentation By Valance, 2020 – 2025
    • Table 193: Global Vaccines Market Size Gain ($ Million), Segmentation By Distribution Channel, 2020 – 2025
    • Table 194: Vaccines - Market Data Sources

    List Of Figures

      Figure 1: Global Vaccines Market Segmentation By Type
    • Figure 2: Global Vaccines Market Segmentation By Technology
    • Figure 3: Global Vaccines Market Segmentation By Route of Administration
    • Figure 4: Global Vaccines Market Segmentation By Valance
    • Figure 5: Global Vaccines Market Segmentation By Distribution Channel
    • Figure 6: Global Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 7: Global Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 8: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Vaccines Market, Segmentation By Route of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Global Vaccines Market, Segmentation By Valance, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 12: Global Vaccines Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 13: Global Vaccines Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: Global Vaccines Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 15: Asia-Pacific Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 16: Asia-Pacific Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 17: Asia-Pacific Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 18: Asia-Pacific Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 19: China Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 20: China Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 21: China Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 22: China Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: India Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 24: India Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: India Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: India Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 27: Japan Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 28: Japan Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 29: Japan Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 30: Japan Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 31: Australia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 32: Australia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 33: Australia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 34: Australia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: Indonesia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 36: Indonesia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: Indonesia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Indonesia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 39: South Korea Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 40: South Korea Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 41: South Korea Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 42: South Korea Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 43: Western Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 44: Western Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 45: Western Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 46: Western Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: UK Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 48: UK Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: UK Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: UK Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 51: Germany Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 52: Germany Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 53: Germany Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 54: Germany Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 55: France Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 56: France Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 57: France Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 58: France Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Eastern Europe Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Eastern Europe Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Eastern Europe Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Eastern Europe Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 63: Russia Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 64: Russia Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 65: Russia Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 66: Russia Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 67: North America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 68: North America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 69: North America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 70: North America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 71: USA Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 72: USA Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 73: USA Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 74: USA Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 75: South America Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 76: South America Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 77: South America Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 78: South America Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 79: Brazil Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 80: Brazil Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 81: Brazil Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 82: Brazil Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 83: Middle East Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 84: Middle East Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 85: Middle East Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 86: Middle East Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 87: Africa Vaccines Market, Historic, 2015 – 2020, $ Million
    • Figure 88: Africa Vaccines Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 89: Africa Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 90: Africa Vaccines Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 91: Global Vaccines Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 92: GlaxoSmithKline plc – Financial Performance, 2016 – 2020, $ Billion
    • Figure 93: Merck & Co., Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 94: Sanofi S.A. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 95: Pfizer Inc. – Financial Performance, 2016 – 2020, $ Billion
    • Figure 96: CSL Limited – Financial Performance, 2016 – 2020, $ Billion
    Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Read More
    Cancer Vaccines Global Market Report 2021 - By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat), By End-User (Cancer Treatment Centers, Research Institutes), COVID-19 Growth And Change
    View Report
    DTP Vaccines Global Market Report 2021 - By Product Type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End User (Hospitals, Clinics, Vaccination Centers), COVID-19 Growth And Change
    View Report
    Cancer Biologics Global Market Report 2021 - By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy), By Application (Hospitals, Clinics), COVID-19 Growth And Change
    View Report
    Drugs For Immunotherapy Global Market Report 2021 - By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), By End User: Hospitals & Clinics, Ambulatory Surgical Centers), COVID-19 Growth And Change
    View Report
    Pediatric Vaccine Global Market Report 2021 - By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer), COVID 19 Growth And Change
    View Report
    Veterinary Vaccines Global Market Report 2021 - By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot & Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive & Respiratory Syndrome (PRRS)), COVID-19 Impact And Recovery
    View Report
    Companion Animal Veterinary Vaccines Global Market Report 2021 - By Product (Inactivated, Live Attenuated, Recombinant), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores), COVID-19 Growth And Change
    View Report
    Pharmaceutical Drugs And Biologics Logistics Market - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)